Q3 2023 Holdings
Filed 2023-11-14 | 140 holdings | $831.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $64.1M | 1,500 | 7.7% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $44.5M | 3,673 | 5.4% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $43.0M | 1,200 | 5.2% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $36.5M | 5,000 | 4.4% |
| Acelyrin Inc | COM | 00445A100 | $29.7M | 2,918,426 | 3.6% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $27.8M | 7,230 | 3.3% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $25.7M | 2,123 | 3.1% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $25.2M | 2,443 | 3.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $23.6M | 792,920 | 2.8% |
| Immunovant Inc(IMVT)Put | COM | 45258J102 | $21.2M | 5,534 | 2.6% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $19.8M | 1,325 | 2.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $15.8M | 536,720 | 1.9% |
| Akero Therapeutics Inc(AKRO)Put | COM | 00973Y108 | $15.4M | 3,049 | 1.9% |
| Crinetics Pharmaceuticals in(CRNX)Put | COM | 22663K107 | $13.5M | 4,543 | 1.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.4M | 654,726 | 1.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $12.8M | 278,034 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $12.5M | 473,126 | 1.5% |
| Crinetics Pharmaceuticals in(CRNX)Call | COM | 22663K107 | $12.1M | 4,054 | 1.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $11.4M | 297,794 | 1.4% |
| Nuvalent Inc(NUVL)Call | COM | 670703107 | $11.0M | 2,395 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX)Put | COM | 87164F105 | $10.9M | 7,500 | 1.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.1M | 200,000 | 1.2% |
| Akero Therapeutics Inc(AKRO)Call | COM | 00973Y108 | $10.1M | 1,989 | 1.2% |
| Krystal Biotech Inc(KRYS)Put | COM | 501147102 | $9.8M | 845 | 1.2% |
| Replimune Group Inc(REPL)Put | COM | 76029N106 | $9.3M | 5,438 | 1.1% |
| Crispr Therapeutics AG(CRSP)Put | NAMEN AKT | H17182108 | $9.3M | 2,039 | 1.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $9.2M | 518,519 | 1.1% |
| Biomarin Pharmaceutical Inc(BMRN)Put | COM | 09061G101 | $9.0M | 1,018 | 1.1% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $9.0M | 2,365 | 1.1% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $8.8M | 12,132 | 1.1% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $8.1M | 3,054 | 1.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.3M | 142,417 | 0.9% |
| Arcus Biosciences Inc(RCUS)Call | COM | 03969F109 | $7.2M | 4,000 | 0.9% |
| Disc Medicine Inc(IRON)Put | COM | 254604101 | $7.2M | 1,526 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.9M | 137,824 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.7M | 142,766 | 0.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.2M | 174,945 | 0.8% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $6.2M | 390,162 | 0.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $6.0M | 746,069 | 0.7% |
| Cytokinetics Inc(CYTK)Put | COM NEW | 23282W605 | $6.0M | 2,035 | 0.7% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $6.0M | 2,035 | 0.7% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $5.9M | 505,862 | 0.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $5.9M | 216,949 | 0.7% |
| Ambrx Biopharma IncCall | SPONSORED ADS | 02290A102 | $5.7M | 4,932 | 0.7% |
| Immunogen Inc(IMGNEUR)Call | COM | 45253H101 | $5.7M | 3,568 | 0.7% |
| Revolution Medicines Inc(RVMD)Put | COM | 76155X100 | $5.6M | 2,035 | 0.7% |
| Jazz Pharmaceuticals PLC(JAZZ)Call | SHS USD | G50871105 | $5.4M | 418 | 0.7% |
| 89Bio Inc(ETNBGBP)Call | COM | 282559103 | $5.4M | 3,504 | 0.7% |
| Novavax Inc(NVAX)Call | COM NEW | 670002401 | $5.2M | 7,132 | 0.6% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $4.9M | 1,254,384 | 0.6% |